Lmp2a Does Not Enhance The Tumorigenic Potential Of Ebv Negative Akata

LMP2A does not enhance the tumorigenic potential of EBV-negative Akata ...
LMP2A does not enhance the tumorigenic potential of EBV-negative Akata ...
LMP2A does not enhance the tumorigenic potential of EBV-negative Akata ...
LMP2A does not enhance the tumorigenic potential of EBV-negative Akata ...
The expression of LMP2A does not enhance cell survival. The data ...
The expression of LMP2A does not enhance cell survival. The data ...
EBERs enhance tumorigenic potential of EBV-negative Akata BL cells ...
EBERs enhance tumorigenic potential of EBV-negative Akata BL cells ...
The oncogenic potential of EBV is outlined in the figure, where the ...
The oncogenic potential of EBV is outlined in the figure, where the ...
EBV infection restores tumorigenic potential to EBV-negative Akata ...
EBV infection restores tumorigenic potential to EBV-negative Akata ...
Generation of novel affibody molecules targeting the EBV LMP2A N ...
Generation of novel affibody molecules targeting the EBV LMP2A N ...
Generation of novel affibody molecules targeting the EBV LMP2A N ...
Generation of novel affibody molecules targeting the EBV LMP2A N ...
The role of LMP2A in EBV biology as a B cell Receptor Mimic – Johannsen ...
The role of LMP2A in EBV biology as a B cell Receptor Mimic – Johannsen ...
The role of LMP2A in EBV biology as a B cell Receptor Mimic – Johannsen ...
The role of LMP2A in EBV biology as a B cell Receptor Mimic – Johannsen ...
EBV, but not EBNA-1, restores tumorigenicity to EBV- negative Akata ...
EBV, but not EBNA-1, restores tumorigenicity to EBV- negative Akata ...
Structures of viral TMPs LMP1, LMP2A and K15. EBV LMP1 is a potent ...
Structures of viral TMPs LMP1, LMP2A and K15. EBV LMP1 is a potent ...
Detection of EBV LMP2a specific T cells after rituximab therapy ...
Detection of EBV LMP2a specific T cells after rituximab therapy ...
The expression of LMP2A correlates with the expression of EMT and stem ...
The expression of LMP2A correlates with the expression of EMT and stem ...
Enhanced growth potential of EBV-positive Akata cells is indepen- dent ...
Enhanced growth potential of EBV-positive Akata cells is indepen- dent ...
LMP2B overexpression increases the magnitude of EBV lytic activation ...
LMP2B overexpression increases the magnitude of EBV lytic activation ...
High detection frequency of latency phase EBV proteins, LMP1 and LMP2A ...
High detection frequency of latency phase EBV proteins, LMP1 and LMP2A ...
Schematic diagram of potential mechanisms for EBV promoting HERV ...
Schematic diagram of potential mechanisms for EBV promoting HERV ...
LMP2B overexpression increases the magnitude of EBV lytic activation ...
LMP2B overexpression increases the magnitude of EBV lytic activation ...
Viruses | Special Issue : The Roles of EBV Infection in the Internal ...
Viruses | Special Issue : The Roles of EBV Infection in the Internal ...
LMP2B silencing, LMP2A overexpression and LMP2A silencing in Akata ...
LMP2B silencing, LMP2A overexpression and LMP2A silencing in Akata ...
LMP2A expression and phosphorylation in retrovirally infected EBV Ϫ ...
LMP2A expression and phosphorylation in retrovirally infected EBV Ϫ ...
Specific Immune Responses and Oncolytic Effects Induced by EBV LMP2A ...
Specific Immune Responses and Oncolytic Effects Induced by EBV LMP2A ...
Induction of EBV latent membrane protein-2A (LMP2A)-specific T cells ...
Induction of EBV latent membrane protein-2A (LMP2A)-specific T cells ...
Analysis of the binding specificity of the Z LMP2A-N affibodies for ...
Analysis of the binding specificity of the Z LMP2A-N affibodies for ...
Induction of EBV latent membrane protein-2A (LMP2A)-specific T cells ...
Induction of EBV latent membrane protein-2A (LMP2A)-specific T cells ...
Specific Immune Responses and Oncolytic Effects Induced by EBV LMP2A ...
Specific Immune Responses and Oncolytic Effects Induced by EBV LMP2A ...
Induction of EBV latent membrane protein-2A (LMP2A)-specific T cells ...
Induction of EBV latent membrane protein-2A (LMP2A)-specific T cells ...
Akt is constitutively phosphorylated in EBV ϩ LMP2A ϩ LCLs. EBV ϩ LMP2A ...
Akt is constitutively phosphorylated in EBV ϩ LMP2A ϩ LCLs. EBV ϩ LMP2A ...
Latent Membrane Protein LMP2A Impairs Recognition of EBV-Infected Cells ...
Latent Membrane Protein LMP2A Impairs Recognition of EBV-Infected Cells ...
Latent Membrane Protein LMP2A Impairs Recognition of EBV-Infected Cells ...
Latent Membrane Protein LMP2A Impairs Recognition of EBV-Infected Cells ...
Latent Membrane Protein LMP2A Impairs Recognition of EBV-Infected Cells ...
Latent Membrane Protein LMP2A Impairs Recognition of EBV-Infected Cells ...
Latent Membrane Protein LMP2A Impairs Recognition of EBV-Infected Cells ...
Latent Membrane Protein LMP2A Impairs Recognition of EBV-Infected Cells ...
Latent Membrane Protein LMP2A Impairs Recognition of EBV-Infected Cells ...
Latent Membrane Protein LMP2A Impairs Recognition of EBV-Infected Cells ...
Epstein-Barr virus LMP2A bypasses p53 inactivation in a MYC model of ...
Epstein-Barr virus LMP2A bypasses p53 inactivation in a MYC model of ...
LMP1 mediates RON expression. EBV- negative Akata cells were ...
LMP1 mediates RON expression. EBV- negative Akata cells were ...

Loading image details...

Source
Dimensions